Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Diagnostic
- Imaging
- Therapeutic
- Proteins
- Medical
- 3D
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 237211
For License to Licensor Leads, Collaboration Leads and Licensee Leads, Licensor grants an exclusive worldwide license, with the right to grant sublicenses, to use the Licensor Leads, Collaboration Leads and Licensee Leads and Collaboration Results pursuant to a Collaboration Project or a Licensee Project to research, develop, make, have made, use, import and have sold Licensed Products in the Diagnostic Imaging Field.
For the Option in the Licensee Therapeutics Field, the License Option, with regard to any Licensor Lead for which a Collaboration Project exists and for any Collaboration Lead or Licensee Lead, Licensee may extend the license rights granted to the exclusive use of such lead to research, develop, make, have made, use, import and have sold Licensed Products in the Licensee Therapeutics Field and will have a non-exclusive license to use the Licensor Technology in the Licensee Therapeutics Field in connection therewith; provided that such lead is not part of an active Licensor research and development program or that Licensor is not precluded from granting the license because of an agreement with a third party.
Licensor Technology shall mean collectively any proprietary peptide, protein and antibody library technology and/or all related materials, data, know-how, inventions and Patent Rights that Licensor owns or controls and has the right to grant licenses to in the Diagnostic Imaging Field existing or arising during and through the Research Term.
Licensor Leads shall mean any peptide, protein or antibody molecules existing as of the Effective Date, including Proteases, Antibodies, Blood Proteins , Cell Surface Receptors·, Signal Transduction Components, and, Viruses, and any peptide, protein or antibody molecules that Licensor thereafter owns or controls and has the right to grant licenses in the Diagnostic Imaging Field after the Effective Date for so long as Licensee maintains the exclusive license to the Licensor Technology in the Diagnostic Imaging Field, and any data, know-how, inventions and Patent Rights pertaining to such Licensor Leads. Licensor Leads shall not include any Collaboration Leads.
Collaboration Leads shall mean any peptide, protein or antibody molecule and the sequence contained therein and derivatives thereof, resulting from or pertaining to any Collaboration Project commenced during the Research Term and that exist at the time of termination of the Research Term and associated Patent Rights, other than Licensor Leads.
Licensee Leads shall mean any peptide, protein or antibody molecule and the sequence contained therein and derivatives thereof discovered by Licensee after the Research Term using any of the Licensor Technology or Licensor Improvements and associated Patent Rights.
Collaboration Results shall mean any Collaboration Leads and other materials, information, data, and know-how, whether or not patentable, that result from any Collaboration Project that is useful by Licensee in the Collaboration Field or by Licensor in all fields except the Collaboration Field, and any Patent Rights covering inventions resulting from such Collaboration Project, excluding Licensor Technology and Licensor Improvements and Barriers Carrier and Licensee Improvements.
Licensed Product shall mean any product that consists of, includes or was derived from any Licensor Lead, Collaboration Lead or Licensee Lead for which Formal Development has commenced or which arose out of a Collaboration Project.
Diagnostic Imaging Field shall mean any in vivo use in medical imaging, including radiopharmaceutical, ultrasound, MRI and X-ray and light imaging.
Licensee possesses intellectual property, technology and expertise relating to the research, development and commercialization of diagnostic imaging products and radiopharmaceuticals.
IPSCIO Record ID: 148361
– the sole and exclusive worldwide right and license, with no right to sublicense under both the Licensors Technology and interest in any Joint Technology, to use the Licensor Transporters for the identification and/or development of Lead Compounds and Collaboration Products in the Field of Use;
– the sole and exclusive worldwide right and license, with the right to sublicense to Affiliates of Licensee and/or one or more Third Parties, under both the Licensor Technology and interest in any Joint Technology, to make, have made, use, import, market, offer for sale and sell Lead Compounds and Collaboration Products in the Field of Use;
– during the term of the Research Program, the sole and exclusive right and license, with no right to sublicense, under both the Licensor Ancillary Transporter Technology and interest in any Joint Technology, to use the Licensor Ancillary Transporters for the sole purpose of conducting selectivity testing of Lead Compounds and Collaboration Products;
– after the term of the Research Program, a non-exclusive right and license, with no right to sublicense, under the Licensor Ancillary Transporter Technology to use the Licensor Ancillary Transporters for the sole purpose of conducting selectivity testing of Lead Compounds and Collaboration Products;
– during the term of this Agreement, a nonexclusive right and license, with no right to sublicense, to use all data and information generated by or on behalf of Licensor in the conduct of the Research Program, including data relating to Hits in the Licensor Proprietary Chemical Library, but only as shall be reasonably necessary for Licensee to conduct research to identify and develop Lead Compounds and Collaboration Products, provided, however, that such license shall become sole and exclusive when a Compound is designated a Lead Compound in accordance with Article Six and shall revert to a non-exclusive license upon determination of the Steering Committee or Licensee that such Lead Compound will not become a Collaboration Product;
– during the term of this Agreement, an exclusive right and license, with the right to sublicense, to use all data and information generated by or on behalf of Licensor in the conduct of the Research Program relating to Lead Compounds and/or Collaboration Products in the Licensor Proprietary Chemical Library, but only as shall be reasonably necessary for Licensee to conduct research to identify and develop Lead Compounds and Collaboration Products; and
– during the term of this Agreement, a non-exclusive right and license, with no right to sublicense, to use the Licensor Materials but only to the extent that such right and license shall be necessary for Licensee to identify and develop Lead Compounds and Collaboration Products.
Glutamate transporters are a family of neurotransmitter transporter proteins that move glutamate – the principal excitatory neurotransmitter – across a membrane.
Licensor Transporters mean EAAT-2 and EAAT-3 protein of amino-acid compositions.
IPSCIO Record ID: 237233
Licensor grants a non-exclusive, worldwide license to Licensor Patent Rights, Technology and Improvements to research, develop, make, have made, use, import, offer to sell and sell collaboration products and non-collaboration products in the Field of Use and to sublicense solely the research, development, manufacture, use, importation and sale of such collaboration products and non-collaboration products in the Field of Use.
Licensor grants an exclusive, worldwide license to research, develop, make, have made, use, import, offer to sell and sell collaboration products in the Field of Use and to sublicense the research, development, manufacture, use, importation and sale of such collaboration products in the Field of Use.
Licensor grants a non-exclusive, worldwide license to Licensor Patent Rights to research, develop, make, have made, use, import, offer to sell and sell non-Licensor products in the Field of Use and to sublicense solely the research, development, manufacture, use, importation and sale of such non-Licensor products in the Field of Use.
The patents relate to Gene encoding and novel protein binding, but specifically exclude Claim 66 in U.S. Patent No. 5,223,409 to the extent that it covers DNA molecules encoding single chain antibodies, or (ii) any claim to specific protein or peptide sequences, or nucleic acids encoding the same, that bind to a specific biological or molecular target.
Research Reagent Field shall mean the use of one or more peptides, antibodies, or antibody-antigen or peptide-target combinations (whether in a microarray format or other format) for research purposes.
Therapeutic Field shall mean all human therapeutic and prophylactic uses, and any in vivo diagnostic uses for a Licensee Target which is necessary for HGS successful commercialization of a human therapeutic or prophylactic Collaboration Product, non-collaboration product or non-Licensor product.
Diagnostic Field shall mean all in vitro research, analysis, detection or diagnostic uses, and not for any in vivo diagnostic, therapeutic, purification_ or separations, agricultural, industrial enzyme or other uses.
Licensor Field shall mean all agricultural, industrial enzyme, and purification and separation uses.
IPSCIO Record ID: 133583
